LG Chem Announces Partnership with UK's LabGenius Therapeutics
LG Chem has partnered with the UK-based LabGenius Therapeutics to jointly develop new antibody-based cancer drug candidates. This collaboration involves an upfront payment and R&D funding from LG Chem, with future decisions on further development and licensing based on research outcomes. The news also touches upon Dreame's strategic focus on smart homes, outdoor spaces, smart mobility, and embodied intelligence, highlighting their success in robot vacuums, lawnmowers, and floor washers. AI
IMPACT This partnership could lead to advancements in AI-driven drug discovery and development, potentially accelerating the creation of new cancer therapies.